[go: up one dir, main page]

ZA922298B - Device for reducing sensation during iontophoretic drug delivery - Google Patents

Device for reducing sensation during iontophoretic drug delivery

Info

Publication number
ZA922298B
ZA922298B ZA922298A ZA922298A ZA922298B ZA 922298 B ZA922298 B ZA 922298B ZA 922298 A ZA922298 A ZA 922298A ZA 922298 A ZA922298 A ZA 922298A ZA 922298 B ZA922298 B ZA 922298B
Authority
ZA
South Africa
Prior art keywords
drug delivery
sensation
iontophoretic drug
sensation during
during iontophoretic
Prior art date
Application number
ZA922298A
Other languages
English (en)
Inventor
J Bradley Phipps
Bradley Phipps J
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of ZA922298B publication Critical patent/ZA922298B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/20—Applying electric currents by contact electrodes continuous direct currents
    • A61N1/30—Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Electrotherapy Devices (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Electrostatic Spraying Apparatus (AREA)
ZA922298A 1991-04-02 1992-03-30 Device for reducing sensation during iontophoretic drug delivery ZA922298B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/679,425 US5221254A (en) 1991-04-02 1991-04-02 Method for reducing sensation in iontophoretic drug delivery

Publications (1)

Publication Number Publication Date
ZA922298B true ZA922298B (en) 1993-01-27

Family

ID=24726864

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA922298A ZA922298B (en) 1991-04-02 1992-03-30 Device for reducing sensation during iontophoretic drug delivery

Country Status (12)

Country Link
US (2) US5221254A (fr)
EP (1) EP0578773B1 (fr)
JP (1) JP3343348B2 (fr)
AT (1) ATE140630T1 (fr)
AU (1) AU1773792A (fr)
DE (1) DE69212468T2 (fr)
ES (1) ES2089532T3 (fr)
IE (1) IE921009A1 (fr)
MX (1) MX9201439A (fr)
PT (1) PT100323B (fr)
WO (1) WO1992017239A1 (fr)
ZA (1) ZA922298B (fr)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5221254A (en) * 1991-04-02 1993-06-22 Alza Corporation Method for reducing sensation in iontophoretic drug delivery
CA2151741C (fr) * 1991-12-30 2001-12-11 Alan Justice Methode analgesique et amelioration d'une methode analgesique utilisant un opiace
AU7923794A (en) * 1993-09-30 1995-04-18 Becton Dickinson & Company Iontophoretic drug delivery system and method
US5540669A (en) * 1993-09-30 1996-07-30 Becton, Dickinson And Company Iontophoretic drug delivery system and method for using same
EP0752898B1 (fr) * 1994-03-30 1998-04-29 Alza Corporation Reduction de l'irritation de la peau pendant l'administration de medicament par electrotransport
US5498235A (en) * 1994-09-30 1996-03-12 Becton Dickinson And Company Iontophoresis assembly including patch/controller attachment
US5861439A (en) * 1994-11-14 1999-01-19 Alza Corporation Method for enhanced electrotransport agent delivery
US5611594A (en) * 1995-04-13 1997-03-18 Findlay; Robert Portable folding chair
US5935598A (en) * 1996-06-19 1999-08-10 Becton Dickinson Research Center Iontophoretic delivery of cell adhesion inhibitors
US6157858A (en) * 1996-12-26 2000-12-05 Elan Pharma International Limited Device for the delivery of a substance to a subject and improved electrode assembly
AU5337998A (en) * 1996-12-26 1998-07-31 Elan International Services Limited Device for the delivery of a substance to a subject and improved electrode assembly
US6018679A (en) * 1997-01-29 2000-01-25 Novartis Finance Corp. Iontophoretic transdermal delivery and control of adverse side-effects
JP3366548B2 (ja) * 1997-02-26 2003-01-14 久光製薬株式会社 イオントフォレーシス用デバイス構造体及びその製造方法
US6119036A (en) * 1997-03-26 2000-09-12 The Board Of Regents Of The University Of Oklahoma Iontophoretic transdermal delivery device
EP0898962A1 (fr) * 1997-08-28 1999-03-03 Becton, Dickinson and Company Emplâtres transdermiques et méthodes d'inactivation de protéases de la peau
KR100315160B1 (ko) * 1998-01-09 2002-05-13 김충섭 피부수렴제가첨가된경피투여용약제조성물
ATE343411T1 (de) * 1998-08-31 2006-11-15 Travanti Pharma Inc Gesteuerte medikamentdosierungsvorrichtung
US6475514B1 (en) 1998-12-03 2002-11-05 Andrew Blitzer Athletic patch
US6421561B1 (en) * 1999-12-30 2002-07-16 Birch Point Medical, Inc. Rate adjustable drug delivery system
US6653014B2 (en) 2001-05-30 2003-11-25 Birch Point Medical, Inc. Power sources for iontophoretic drug delivery systems
AU2003282683A1 (en) * 2002-10-04 2004-05-04 Photokinetix Inc. Photokinetic delivery of biologically active substances using pulsed incoherent light
US7220778B2 (en) * 2003-04-15 2007-05-22 The General Hospital Corporation Methods and devices for epithelial protection during photodynamic therapy
US8252321B2 (en) 2004-09-13 2012-08-28 Chrono Therapeutics, Inc. Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
EP1802258A4 (fr) 2004-09-13 2015-09-23 Chrono Therapeutics Inc Administration de medicament transdermique biosynchrone
US20070042026A1 (en) * 2005-03-17 2007-02-22 Wille John J Prophylactic and therapeutic treatment of topical and transdermal drug-induced skin reactions
WO2006127905A2 (fr) 2005-05-24 2006-11-30 Chrono Therapeutics, Inc. Dispositif d'apport de medicament portatif comprenant un element de dosage et d'administration detachable et remplaçable
US20080193514A1 (en) * 2006-11-02 2008-08-14 Transcu Ltd. Compostions and methods for iontophoresis delivery of active ingredients through hair follicles
JPWO2008087803A1 (ja) * 2007-01-16 2010-05-06 国立大学法人北海道大学 抗酸化成分を封入したイオントフォレーシス用リポソーム製剤
US20080188791A1 (en) * 2007-02-02 2008-08-07 Difiore Attilio E Active iontophoresis delivery system
US8197844B2 (en) 2007-06-08 2012-06-12 Activatek, Inc. Active electrode for transdermal medicament administration
JP2010187707A (ja) * 2007-06-12 2010-09-02 Hokkaido Univ インスリンを封入したイオントフォレーシス用リポソーム製剤
WO2009003173A1 (fr) * 2007-06-27 2008-12-31 The General Hospital Corporation Procédé et appareil d'inhibition optique de traitement photodynamique
US8862223B2 (en) 2008-01-18 2014-10-14 Activatek, Inc. Active transdermal medicament patch and circuit board for same
CN103118738B (zh) * 2010-09-21 2015-06-24 皇家飞利浦电子股份有限公司 电极设备
US20130017259A1 (en) 2011-07-06 2013-01-17 The Parkinson's Institute Compositions and Methods for Treatment of Symptoms in Parkinson's Disease Patients
US10105487B2 (en) 2013-01-24 2018-10-23 Chrono Therapeutics Inc. Optimized bio-synchronous bioactive agent delivery system
CA2974324A1 (fr) 2015-01-28 2016-08-04 Zita S. Netzel Procedes et systemes d'administration de medicament
JP2018511127A (ja) 2015-03-12 2018-04-19 クロノ セラピューティクス インコーポレイテッドＣｈｒｏｎｏ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｉｎｃ． 渇望入力及び支援システム
WO2018035443A1 (fr) * 2016-08-19 2018-02-22 University Of Cincinnati Stimulation de transpiration prolongée
EP3565617A1 (fr) 2017-01-06 2019-11-13 Chrono Therapeutics Inc. Dispositifs et methodes d'administration transdermique de medicament
AU2019279884B2 (en) 2018-05-29 2025-01-30 Morningside Venture Investments Limited Drug delivery methods and systems
WO2020102695A1 (fr) 2018-11-16 2020-05-22 Cti (Assignment For Benefit Of Creditors) Llc Système d'administration transdermique de médicaments à régulation thermique

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE399044A (fr) * 1933-09-09
US3991755A (en) * 1973-07-27 1976-11-16 Medicon, Inc. Iontophoresis apparatus for applying local anesthetics
US4405616A (en) * 1975-06-19 1983-09-20 Nelson Research & Development Company Penetration enhancers for transdermal drug delivery of systemic agents
US3989816A (en) * 1975-06-19 1976-11-02 Nelson Research & Development Company Vehicle composition containing 1-substituted azacycloheptan-2-ones
US4141359A (en) * 1976-08-16 1979-02-27 University Of Utah Epidermal iontophoresis device
US4211222A (en) * 1976-08-25 1980-07-08 Robert Tapper Iontophoretic burn-protection method
US4340047A (en) * 1978-10-18 1982-07-20 Robert Tapper Iontophoretic treatment apparatus
US4250878A (en) * 1978-11-22 1981-02-17 Motion Control, Inc. Non-invasive chemical species delivery apparatus and method
JPS56501274A (fr) * 1979-10-10 1981-09-10
US4424210A (en) * 1980-04-04 1984-01-03 Nelson Research & Development Company Vehicle composition containing 1-substituted azacycloalkan-2-ones
US4415563A (en) * 1980-04-04 1983-11-15 Nelson Research & Development Company Vehicle composition containing 1-substituted azacyclononan-2-ones
US4382529A (en) * 1980-12-15 1983-05-10 Drdlik Frank J Sanitary dispensing closure
US4416274A (en) * 1981-02-23 1983-11-22 Motion Control, Inc. Ion mobility limiting iontophoretic bioelectrode
US4406658A (en) * 1981-03-06 1983-09-27 Medtronic, Inc. Iontophoretic device with reversible polarity
US4744787A (en) * 1984-10-29 1988-05-17 Medtronic, Inc. Iontophoresis apparatus and methods of producing same
US4747819A (en) * 1984-10-29 1988-05-31 Medtronic, Inc. Iontophoretic drug delivery
FI863192L (fi) * 1984-12-07 1986-08-05 Mepha Ag Preparat foer intramuskulaer injektering av mediciner, vitaminer eller vaccin.
DE3507301A1 (de) * 1985-03-01 1986-09-04 Arbo GmbH Medizin-Technologie, 38100 Braunschweig Bioelektrische elektrode
EP0225871B1 (fr) * 1985-06-10 1990-03-14 Drug Delivery Systems Inc. Systeme et procede de regulation de la vitesse de liberation electrocinetique d"un medicament
US4722726A (en) * 1986-02-12 1988-02-02 Key Pharmaceuticals, Inc. Method and apparatus for iontophoretic drug delivery
US4752285B1 (en) * 1986-03-19 1995-08-22 Univ Utah Res Found Methods and apparatus for iontophoresis application of medicaments
IE60941B1 (en) * 1986-07-10 1994-09-07 Elan Transdermal Ltd Transdermal drug delivery device
DE3703321A1 (de) * 1986-09-01 1988-03-10 Transcutan Gmbh Therapievorrichtung zur anwendung von elektrischem strom
US4822334A (en) * 1986-12-04 1989-04-18 Robert Tapper Electrical dosimetry control system
FR2616333A1 (fr) * 1987-06-12 1988-12-16 Cird Procede d'ionophorese pour administrer une substance dissoute ou partiellement dissoute, par voie percutanee ou perungueale et dispositif correspondant
EP0318776A1 (fr) * 1987-12-04 1989-06-07 Robert Tapper Méthode et dispositif pour minimaliser les lésions de la peau causées par l'utilisation d'électrodes
US5006108A (en) * 1988-11-16 1991-04-09 Noven Pharmaceuticals, Inc. Apparatus for iontophoretic drug delivery
US4992508A (en) * 1989-06-16 1991-02-12 Imaginative Research Associates, Inc. Aqueous dispersions of polyester and polyesteramides cross-linked with metallic ions and casts made therefrom
US5167616A (en) * 1989-12-14 1992-12-01 Alza Corporation Iontophoretic delivery method
US5221254A (en) * 1991-04-02 1993-06-22 Alza Corporation Method for reducing sensation in iontophoretic drug delivery
US5246418A (en) * 1991-12-17 1993-09-21 Becton Dickinson And Company Iontophresis system having features for reducing skin irritation

Also Published As

Publication number Publication date
US5221254A (en) 1993-06-22
IE921009A1 (en) 1992-10-07
JPH06506616A (ja) 1994-07-28
JP3343348B2 (ja) 2002-11-11
DE69212468T2 (de) 1996-12-12
ES2089532T3 (es) 1996-10-01
AU1773792A (en) 1992-11-02
PT100323B (pt) 1999-04-30
EP0578773B1 (fr) 1996-07-24
ATE140630T1 (de) 1996-08-15
PT100323A (pt) 1994-04-29
DE69212468D1 (de) 1996-08-29
MX9201439A (es) 1992-10-01
US5403275A (en) 1995-04-04
WO1992017239A1 (fr) 1992-10-15
EP0578773A1 (fr) 1994-01-19

Similar Documents

Publication Publication Date Title
ZA922298B (en) Device for reducing sensation during iontophoretic drug delivery
CA2218369A1 (fr) Administration transdermique par electrotransport de fentanyl et de sufentanil
WO2002036072A3 (fr) Procede pour une dosimetrie de medicaments a court et a long terme
ZA95743B (en) Therapeutic agents
DE69735848D1 (de) Dosisform mit ansteigender dosisfreisetzung
AU5876596A (en) Oral dosage and method for treating painful conditions of th e oral cavity
NZ296893A (en) Treatment/prevention of adverse reactions to skin irritants by administration of a loop diuretic optionally in conjunction with a mast cell degranulator or a glucocorticosteroid;transdermal delivery device
GB2317115A (en) Device for transdermal electrotransport delivery of fentanyl and sufentanil
AU4801497A (en) Dosage form and method for administering drug
AU2003268144A1 (en) Transdermal dosage form comprising an active agent and a salt and free-baseform of an antagonist
EP0195643A3 (en) Compositions and method of controlling transdermal penetration of topical and systemic agents
GR3030418T3 (en) Method and compositions for the treatment of cerebral palsy.
NZ503233A (en) Synergistic analgesic combination of opioid analgesic and COX-2 inhibitor
DE69220808D1 (de) Vorrichtung zur verabreichung von heilmitteln
ZA933349B (en) Transdermal administration of oxybutynin
HU9602356D0 (en) Drug targeting system, method for preparing same and its use
GR3021424T3 (en) Use of 3-guanidinopropionic acid in the manufacture of a medicament for the treatment and prevention of excess adiposity
ZA973444B (en) Transdermally administered dextromethorphan as antitussive agents.
CA2219406A1 (fr) Dispositif d'administration par electrotransport transdermique de fentanyl et de sufentanil
FR2729295B1 (fr)
EP0572110A3 (fr) Réduction et prévention de la toxicité associées au traitement antirétrovirus par la stimulation du taux de glutathione intracellulaire
AU643760B2 (en) Method and composition for increased skin concentration of active agents by iontophoresis
NZ502405A (en) Transdermal therapy system (tts) for releasing an active agent into an organism through the skin and method for applying said transdermal therapy system to the skin
AU634867B2 (en) Method and composition for iontophoresis
AU4042795A (en) Treatment of non-small cell lung carcinoma